BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 19950198)

  • 21. [Correlation of p38 mitogen-activated protein kinase signal transduction pathway to uPA expression in breast cancer].
    Han YC; Zeng XX; Wang R; Zhao Y; Li BL; Song M
    Ai Zheng; 2007 Jan; 26(1):48-53. PubMed ID: 17222367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Signal transduction of MEK/ERK and PI3K/Akt activation by hypoxia/reoxygenation in renal epithelial cells.
    Kwon DS; Kwon CH; Kim JH; Woo JS; Jung JS; Kim YK
    Eur J Cell Biol; 2006 Nov; 85(11):1189-99. PubMed ID: 16860436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CrkL plays a role in SDF-1-induced activation of the Raf-1/MEK/Erk pathway through Ras and Rac to mediate chemotactic signaling in hematopoietic cells.
    Arai A; Aoki M; Weihua Y; Jin A; Miura O
    Cell Signal; 2006 Dec; 18(12):2162-71. PubMed ID: 16781119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protein synthesis inhibitor anisomycin induces macrophage apoptosis in rabbit atherosclerotic plaques through p38 mitogen-activated protein kinase.
    Croons V; Martinet W; Herman AG; Timmermans JP; De Meyer GR
    J Pharmacol Exp Ther; 2009 Jun; 329(3):856-64. PubMed ID: 19286921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coordinating ERK/MAPK signalling through scaffolds and inhibitors.
    Kolch W
    Nat Rev Mol Cell Biol; 2005 Nov; 6(11):827-37. PubMed ID: 16227978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The p38 MAP kinase inhibitor SB203580 enhances nuclear factor-kappa B transcriptional activity by a non-specific effect upon the ERK pathway.
    Birkenkamp KU; Tuyt LM; Lummen C; Wierenga AT; Kruijer W; Vellenga E
    Br J Pharmacol; 2000 Sep; 131(1):99-107. PubMed ID: 10960075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Convergence of CD19 and B cell antigen receptor signals at MEK1 in the ERK2 activation cascade.
    Li X; Carter RH
    J Immunol; 1998 Dec; 161(11):5901-8. PubMed ID: 9834070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo.
    Hall-Jackson CA; Goedert M; Hedge P; Cohen P
    Oncogene; 1999 Mar; 18(12):2047-54. PubMed ID: 10321729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of alternative pre-mRNA splicing by the ERK MAP-kinase pathway.
    Weg-Remers S; Ponta H; Herrlich P; König H
    EMBO J; 2001 Aug; 20(15):4194-203. PubMed ID: 11483522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of insulin and elevated glucose level on adenosine transport in rat B lymphocytes.
    Sakowicz M; Szutowicz A; Pawelczyk T
    Int Immunol; 2005 Feb; 17(2):145-54. PubMed ID: 15611320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of A(2A) adenosine receptors by proinflammatory cytokines in rat PC12 cells.
    Trincavelli ML; Costa B; Tuscano D; Lucacchini A; Martini C
    Biochem Pharmacol; 2002 Aug; 64(4):625-31. PubMed ID: 12167481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of adenosine receptor ligands in medical imaging by positron emission tomography.
    Holschbach MH; Olsson RA
    Curr Pharm Des; 2002; 8(26):2345-52. PubMed ID: 12369949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine receptors and asthma in humans.
    Wilson CN
    Br J Pharmacol; 2008 Oct; 155(4):475-86. PubMed ID: 18852693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Signaling by adenosine receptors-Homeostatic or allostatic control?
    Cunha RA
    PLoS Biol; 2019 Apr; 17(4):e3000213. PubMed ID: 30951527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine receptors and the central nervous system.
    Sebastião AM; Ribeiro JA
    Handb Exp Pharmacol; 2009; (193):471-534. PubMed ID: 19639292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-tumor effect of A3 adenosine receptors is potentiated by pulsed electromagnetic fields in cultured neural cancer cells.
    Vincenzi F; Targa M; Corciulo C; Gessi S; Merighi S; Setti S; Cadossi R; Borea PA; Varani K
    PLoS One; 2012; 7(6):e39317. PubMed ID: 22761760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs.
    Jacobson KA; Reitman ML
    Cells; 2020 Apr; 9(4):. PubMed ID: 32295065
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A(2A) adenosine receptors are differentially modulated by pharmacological treatments in rheumatoid arthritis patients and their stimulation ameliorates adjuvant-induced arthritis in rats.
    Vincenzi F; Padovan M; Targa M; Corciulo C; Giacuzzo S; Merighi S; Gessi S; Govoni M; Borea PA; Varani K
    PLoS One; 2013; 8(1):e54195. PubMed ID: 23326596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of adenosine receptors expression in rat B lymphocytes by insulin.
    Sakowicz-Burkiewicz M; Kocbuch K; Grden M; Szutowicz A; Pawelczyk T
    J Cell Biochem; 2010 Feb; 109(2):396-405. PubMed ID: 19950198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetes-induced alterations of adenosine receptors expression level in rat liver.
    Grden M; Podgorska M; Szutowicz A; Pawelczyk T
    Exp Mol Pathol; 2007 Dec; 83(3):392-8. PubMed ID: 17490639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.